Precision Engineering of the Genome, Epigenome, and Transcriptome
Precision Engineering of the Genome, Epigenome, and Transcriptome
批准号:
10237072
负责人:
Thale Cross Jarvis
金额:
$1.98万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-03-04 至 2022-03-03
关键词:
AddressAreaAwarenessBasic ScienceBiotechnologyCell TherapyCell physiologyChromatinClinicClinicalClinical SciencesClinical TrialsCollaborationsCommunitiesConflict (Psychology)DevelopmentDiagnosticDiseaseEducational workshopEmerging TechnologiesEngineeringEventEvolutionGenomeGenome engineeringGovernmentHealthHumanImageIndustrializationInstitutesInterventionKnowledgeLearningMedicalMethodologyMethodsModelingOutcomeParticipantPerformancePhaseRNARecording of previous eventsResearchResearch PersonnelResolutionScientistSeriesSpeedTechnologyTherapeuticTimeTranslationsUnited States National Institutes of HealthUpdateWorkbasebiological systemsclinical applicationclinical implementationclinical practiceepigenomegenome editinghigh throughput screeninghuman diseaseinnovationinterestmeetingsnext generationnovelposterspre-clinicalsingle cell analysissuccesssymposiumsynthetic biologytechnological innovationtooltool developmenttranscriptomevirtual
中文摘要
摘要
请求支持题为《基因组的精密工程》的Keystone研讨会,
首页--期刊主要分类--期刊细介绍--期刊题录与文摘--期刊详细文摘内容
乌尔诺夫。这次会议将是Keystone Symposa的eSymposa会议系列的一部分,这些会议是虚拟的
事件。本次在线会议的日期为2021年3月7日至11日。
在过去的几年里,新的基因组工程工具已经彻底改变了审问
生物系统,设计创新的生物技术,以及模拟和治疗人类疾病。基因组
工程领域继续以疯狂的步伐发展,包括新基础的发展
工具及其在满足社会需求方面的应用。本次Keystone研讨会将讨论这一问题
一系列进展,包括基因组、表观基因组和
转录组精密工程。会议还将重点介绍人类发展的最新进展。
使用这些工具的治疗,包括新的临床试验结果和新模式的临床前范例
干预的结果。会议将包括广泛的研究界感兴趣的各种主题,
包括下一代应用,如高通量筛选、合成生物学和染色质
以及核糖核酸成像和诊断。最后,会议最后将列举一些例子,说明新兴的
可以集成各种技术,以实现前所未有的细胞过程分辨率,例如基因组
工程学与单细胞分析方法相结合。总体而言,本次会议将在其历史的基础上
通过让受众熟悉工具开发的最新进展取得成功,提供了关于
这些工具的临床应用,并对受影响的科学领域的广度产生赞赏
基因组工程革命。
英文摘要
ABSTRACT
Support is requested for a Keystone Symposia conference entitled Precision Engineering of the Genome,
Epigenome and Transcriptome, organized by Drs. Charles Gersbach, Rachel E. Haurwitz and Fyodor D.
Urnov. The conference will be part of Keystone Symposia’s eSymposia Conference Series, which are virtual
events. The dates for this online conference will be March 7-11, 2021.
Over the last several years, new genome engineering tools have revolutionized the ability to interrogate
biological systems, engineer innovative biotechnologies, and model and treat human disease. The genome
engineering field continues to evolve at a frenzied pace, including both the development of new fundamental
tools and their application to addressing societal needs. This Keystone Symposia conference will cover this
spectrum of advances, including the most recent technological innovations in genome, epigenome, and
transcriptome precision engineering. The conference will also highlight recent advances in developing human
therapeutics with these tools, including emerging clinical trial results and preclinical examples of novel modes
of intervention. The conference will include a variety of topics of interest to the broad research community,
including next-generation applications such as high-throughput screening, synthetic biology, and chromatin
and RNA imaging and diagnostics. Finally, the conference will conclude with examples of how emerging
technologies can be integrated for an unprecedented level of resolution of cellular processes, such as genome
engineering combined with single-cell analysis methods. Collectively, this meeting will build on its history of
success by familiarizing the audience with the latest advances in tool development, providing an update on
clinical application of these tools, and generating an appreciation for the breadth of scientific areas impacted by
the Genome Engineering Revolution.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bioenergetics in Health and Diseases
-
批准号:10609120
-
项目类别:
-
资助金额:$1.74万
-
财政年份:2023
-
负责人:Thale Cross Jarvis
-
依托单位:
Autophagy and Neurodegeneration: Mechanisms to Therapies
-
批准号:10608666
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2023
-
负责人:Thale Cross Jarvis
-
依托单位:
Adipose Tissue: Energizing Good Fat
-
批准号:10609127
-
项目类别:
-
资助金额:$2.02万
-
财政年份:2023
-
负责人:Thale Cross Jarvis
-
依托单位:
Cancer Neoantigens, Vaccines and Viruses
-
批准号:10233861
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Small Regulatory RNAs: From Bench to Bedside
-
批准号:10462420
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Engineering Multi-Cellular Living Systems
-
批准号:10462913
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Malaria: Confronting Challenges From Drug Discovery to Treatment
-
批准号:10468493
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Gut-Brain Axis
-
批准号:10467819
-
项目类别:
-
资助金额:$1.72万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
The Human Microbiome: Ecology and Evolution
-
批准号:10391370
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Modern Phenotypic Drug Discovery: From Chemical Biology to Therapeutics
-
批准号:10468419
-
项目类别:
-
资助金额:$1.72万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Drug Delivery to the Brain: Challenges and Progress
-
批准号:10540503
-
项目类别:
-
资助金额:$1.77万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Neurocircuitry of Social Behavior
-
批准号:10540465
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Progress in Vaccine Development for Infectious Diseases
-
批准号:10467880
-
项目类别:
-
资助金额:$0.55万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Resolution of Inflammation
-
批准号:10469175
-
项目类别:
-
资助金额:$0.9万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Organoids as Tools for Fundamental Discovery and Translation
-
批准号:10469084
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Tissue Fibrosis and Repair: Mechanisms, Human Disease and Therapies
-
批准号:10462412
-
项目类别:
-
资助金额:$1.8万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Novel Approaches Against Emerging Antimicrobial Resistance
-
批准号:10391767
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Precision Genome Engineering
-
批准号:10391367
-
项目类别:
-
资助金额:$2.22万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Neuronal Control of Appetite
-
批准号:10468571
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Innate Immunity: Complement and Beyond
-
批准号:10464340
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: